Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 856 AL 870

Interaction between Alzheimer's Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers

Kim SE, Kim HJ, Jang H, Weiner MW, DeCarli C, Na DL, Seo SW.

Int J Mol Sci. 2022 Sep 10;23(18):10490. doi: 10.3390/ijms231810490.

Willis Lecture: Biomarkers for Inflammatory White Matter Injury in Binswanger Disease Provide Pathways to Precision Medicine

Rosenberg GA.

Stroke. 2022 Nov;53(11):3514-3523. doi: 10.1161/STROKEAHA.122.039211. Epub 2022 Sep 23.

Modulation of Amyloid-β and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and Donepezil

Alvarez XA, Winston CN, Barlow JW, Sarsoza FM, Alvarez I, Aleixandre M, Linares C, García-Fantini M, Kastberger B, Winter S, Rissman RA.

J Alzheimers Dis. 2022;90(2):705-717. doi: 10.3233/JAD-220575.

Somatic Mutations and Alzheimer's Disease

Downey J, Lam JCK, Li VOK, Gozes I.

J Alzheimers Dis. 2022;90(2):475-493. doi: 10.3233/JAD-220643.

A Review of Application of Aβ42/40 Ratio in Diagnosis and Prognosis of Alzheimer's Disease

Xu C, Zhao L, Dong C.

J Alzheimers Dis. 2022;90(2):495-512. doi: 10.3233/JAD-220673.

Proteomic Markers and Early Prediction of Alzheimer's Disease

Zakharova NV, Bugrova AE, Indeykina MI, Fedorova YB, Kolykhalov IV, Gavrilova SI, Nikolaev EN, Kononikhin AS.

Biochemistry (Mosc). 2022 Aug;87(8):762-776. doi: 10.1134/S0006297922080089.

CSF α-Synuclein and Tau as Biomarkers for Dementia With Lewy Bodies: A Systematic Review and Meta-analysis

Zhang Q, Li J, Quan W, Liu L, Qin Y, Pei X, Su H, Xu J, Chen J.

Alzheimer Dis Assoc Disord. 2022 Oct-Dec 01;36(4):368-373. doi: 10.1097/WAD.0000000000000516. Epub 2022 Sep 12.

Recent progress in the graphene-based biosensing approaches for the detection of Alzheimer's biomarkers

Rouhi N, Akhgari A, Orouji N, Nezami A, Rahimzadegan M, Kamali H.

J Pharm Biomed Anal. 2023 Jan 5;222:115084. doi: 10.1016/j.jpba.2022.115084. Epub 2022 Sep 28.

High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects

Villain N, Planche V, Levy R.

Rev Neurol (Paris). 2022 Dec;178(10):1011-1030. doi: 10.1016/j.neurol.2022.06.012. Epub 2022 Sep 29.

Limbic-Predominant Age-Related TDP-43 Encephalopathy: LATE-Breaking Updates in Clinicopathologic Features and Biomarkers

Duong MT, Wolk DA.

Curr Neurol Neurosci Rep. 2022 Nov;22(11):689-698. doi: 10.1007/s11910-022-01232-4. Epub 2022 Oct 3.

Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors

Hajjar I, Yang Z, Okafor M, Liu C, Waligorska T, Goldstein FC, Shaw LM.

JAMA Netw Open. 2022 Oct 3;5(10):e2235068. doi: 10.1001/jamanetworkopen.2022.35068.

Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4

Weiner MW, Veitch DP, Miller MJ, Aisen PS, Albala B, Beckett LA, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Nosheny R, Okonkwo OC, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2023 Jan;19(1):307-317. doi: 10.1002/alz.12797. Epub 2022 Oct 9.

Successful aging after elective surgery II: Study design and methods

Hshieh TT, Schmitt EM, Fong TG, Arnold S, Cavallari M, Dickerson BC, Dillon ST, Jones RN, Libermann TA, Marcantonio ER, Pascual-Leone A, Shafi MM, Touroutoglou A, Travison TG, Gou RY, Tommet D, Abdeen A, Earp B, Kunze L, Lange J, Vlassakov K, Inouye SK; SAGES II Study Team.

J Am Geriatr Soc. 2023 Jan;71(1):46-61. doi: 10.1111/jgs.18065. Epub 2022 Oct 10.

[Biomarkers for the diagnosis of cognitive impairment - Recommendations from the Swiss Memory Clinics]

Popp J, Georgescu D, Bürge M, Mundwiler-Pachlatko E, Bernasconi L, Felbecker A.

Praxis (Bern 1994). 2022;111(13):738-744. doi: 10.1024/1661-8157/a003913.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias